Management Board ǀ Apogenix
$ 24.99 · 4.7 (795) · In stock
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.
Gene expression profiles in genome instability-based classes of colorectal cancer, BMC Cancer
Maximum Apocalypse, Board Game
Clinical Trials in Glioblastoma ǀ Apogenix
Investors ǀ Apogenix
HERA Technology Platform ǀ Apogenix
Control Board Amlogic-C76 for S19XP/S19j Pro+ - BITMARS
Apogee Property Management – a “high touch” property management service
Preclinical Candidates ǀ Apogenix
Apogee - VJ Electronix
The Handbook of Board Governance: A Comprehensive Guide for Public, Private, and Not-for-Profit Board Members: Leblanc, Richard: 9781118895504: Books